Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now

Page 9 of 12

4. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders: 91

Merck & Co., Inc. (NYSE:MRK) is a biopharmaceutical company that delivers health solutions to advance the treatment and prevention of diseases in animals and people.

Its Pharmaceutical segment offers vaccines and human health pharmaceutical products, typically therapeutic and preventive agents. Its Animal Health segment develops, discovers, manufactures, and markets a range of vaccines and veterinary pharmaceutical products.

Merck & Co., Inc. (NYSE:MRK) plans to manage the effects of tariffs by opening a $1 billion new plant in the US, expected to open by 2030. The plant will be based in Delaware and will manufacture a range of the company’s drugs sold in the US.

Merck CEO Rob Davis told The Wall Street Journal that this strategic step would ensure that Merck & Co., Inc. (NYSE:MRK) sources its US needs from its US sites. He also said that the company’s decision to invest in domestic manufacturing was driven by “what the current administration is doing and what President Trump is trying to achieve.” The company takes the fourth spot on our list of the best pharma stocks to add to your portfolio.

Page 9 of 12